These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7912134)

  • 1. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity.
    Maj J; Klimek V; Gołembiowska K; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(5-6):455-66. PubMed ID: 7912134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849--a competitive antagonist of NMDA receptors.
    Wedzony K; Klimek V; Nowak G
    Pol J Pharmacol; 1995; 47(6):537-40. PubMed ID: 8868377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 1996; 48(5):467-79. PubMed ID: 9112688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1992; 44(4):337-46. PubMed ID: 1363131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
    Maj J; Skuza G; Rogóz Z
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):53-62. PubMed ID: 8105798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors.
    Rogóz Z; Margas W; Skuza G; Solich J; Kuśmider M; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2002; 54(6):593-603. PubMed ID: 12866714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
    Rogóz Z; Wróbel A; Dlaboga D; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2002; 54(4):381-9. PubMed ID: 12523492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
    Bubser M; Keseberg U; Notz PK; Schmidt WJ
    Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on the release of different neurotransmitters.
    Sitges M; Reyes A
    J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term exposure of rats to tramadol alters brain dopamine and alpha 1-adrenoceptor function that may be related to antidepressant potency.
    Faron-Górecka A; Kuśmider M; Inan SY; Siwanowicz J; Piwowarczyk T; Dziedzicka-Wasylewska M
    Eur J Pharmacol; 2004 Oct; 501(1-3):103-10. PubMed ID: 15464068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
    Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
    Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.